These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessment of rhythm and rate control in patients with atrial fibrillation. Prystowsky EN J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S7-10. PubMed ID: 16939436 [TBL] [Abstract][Full Text] [Related]
4. Regulatory pathways for development of antiarrhythmic drugs for management of atrial fibrillation/flutter. Savelieva I; Kirchhof P; Danchin N; de Graeff PA; Camm AJ Europace; 2011 Aug; 13(8):1063-76. PubMed ID: 21810865 [TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all. Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138 [TBL] [Abstract][Full Text] [Related]
6. A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies? Reiffel JA Am J Cardiol; 2008 Sep; 102(6A):3H-11H. PubMed ID: 18790109 [TBL] [Abstract][Full Text] [Related]
7. Management of atrial fibrillation in patients with heart failure. Neuberger HR; Mewis C; van Veldhuisen DJ; Schotten U; van Gelder IC; Allessie MA; Böhm M Eur Heart J; 2007 Nov; 28(21):2568-77. PubMed ID: 17855740 [TBL] [Abstract][Full Text] [Related]
8. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313 [TBL] [Abstract][Full Text] [Related]
9. Management of atrial fibrillation in patients with heart failure. Efremidis M; Pappas L; Sideris A; Filippatos G J Card Fail; 2008 Apr; 14(3):232-7. PubMed ID: 18381187 [TBL] [Abstract][Full Text] [Related]
10. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1. Aronow WS Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kääb S; Schotten U; Wegscheider K; Boriani G; Ezekowitz M; Diener H; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Vardas P; Breithardt G; Camm AJ Thromb Haemost; 2011 Dec; 106(6):1012-9. PubMed ID: 22048744 [TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). Fleischmann KE; Orav EJ; Lamas GA; Mangione CM; Schron EB; Lee KL; Goldman L; Am Heart J; 2009 Jul; 158(1):78-83.e2. PubMed ID: 19540395 [TBL] [Abstract][Full Text] [Related]
13. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Nieuwlaat R; Prins MH; Le Heuzey JY; Vardas PE; Aliot E; Santini M; Cobbe SM; Widdershoven JW; Baur LH; Lévy S; Crijns HJ Eur Heart J; 2008 May; 29(9):1181-9. PubMed ID: 18397874 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure. Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A Eur J Cardiothorac Surg; 2008 Oct; 34(4):771-5. PubMed ID: 18768326 [TBL] [Abstract][Full Text] [Related]
15. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. Van Gelder IC; Hemels ME Europace; 2006 Nov; 8(11):943-9. PubMed ID: 16973685 [TBL] [Abstract][Full Text] [Related]
16. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594 [TBL] [Abstract][Full Text] [Related]
18. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L; Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136 [TBL] [Abstract][Full Text] [Related]
19. Intermediate to long-term results of radiofrequency modified Maze procedure as an adjunct to open-heart surgery. Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A Ann Thorac Surg; 2008 Nov; 86(5):1409-14. PubMed ID: 19049723 [TBL] [Abstract][Full Text] [Related]
20. Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation. Wongcharoen W; Chen SA Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):311-22. PubMed ID: 19296769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]